Applications of Alpha-Amino-Gamma-Butyrolactone Hydrobromide in Industrial Manufacturing

Alpha-Amino-Gamma-Butyrolactone Hydrobromide serves as an advanced chemical intermediate in multiple industrial sectors. We supply this compound to downstream manufacturers who rely on its defined properties for efficient synthesis and precision processing within regulated production environments.

1. Pharmaceutical Intermediates for CNS-Active Drug Synthesis

Pharmaceutical manufacturers use Alpha-Amino-Gamma-Butyrolactone Hydrobromide as a core building block in the synthesis of central nervous system active compounds, including nootropic and neuroprotective actives. Production lines integrate this material during multi-step organic syntheses, specifically for the modification of lactone rings and amino groups present in lead molecules. Operators must maintain controlled temperatures and atmosphere to avoid by-product formation during N-alkylation or bromide-exchange processes. Batch processing requires materials certified under pharmacopeial standards, with close QC monitoring for residual solvents and chirality. Final purification ensures compliance with regulatory submissions.

Industry compliance standards

• USP/NF (United States Pharmacopeia/National Formulary)
• ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients)
• 21 CFR Part 210/211 (FDA cGMP for Finished Pharmaceuticals)
• European Pharmacopoeia (Ph. Eur.) monograph compliance

Typical usage ratio

• 25%–40% molar ratio in active intermediate synthesis; levels adjusted based on the required conversion and target purity of the succedent CNS agent.

Downstream process integration

• Direct incorporation in step-wise condensation and cyclization reactions after the initiation of protected amino alcohols.
• Entry at lactone protection or deprotection phases during multi-stage organic synthesis.
• Used in chiral pool or asymmetric synthesis routes to produce enantiomerically pure actives.

Final product types

• Active pharmaceutical ingredients for nootropic medications
• Intermediates for neuroprotective agents
• Reference standards for CNS-related new chemical entities
• R&D screening compounds for drug discovery

2. Fine Chemical Synthesis: Pyrrolidone Derivative Manufacturing

Chemical synthesis plants employ Alpha-Amino-Gamma-Butyrolactone Hydrobromide to produce a range of specialty pyrrolidone derivatives for coatings, adhesives, and advanced resins. Operators utilize the compound within nitrogen ring-closing reactions and as an aminolactone donor in targeted side-chain modification. Controlled addition during solvent phase reactions ensures reproducibility and high yield, particularly in the formation of functionalized N-alkylpyrrolidones. Downstream QA inspects trace impurity profiles, focusing on bromide residue and final lactam structure. Manufacturers document each batch for industrial registration as an intermediate chemical.

Industry compliance standards

• REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals, EU)
• ISO 9001:2015 Quality Management System
• OECD guidelines for chemical safety assessment
• Globally Harmonized System (GHS) Classification and Labeling

Typical usage ratio

• 10%–25% by weight, adjusted to match the stoichiometry required for functional group transformation and to minimize unreacted starting material.

Downstream process integration

• Stepwise addition to ring-closing and side-chain functionalization stages during pyrrolidone production.
• Entry after initial alkylation but prior to final purification and distillation.
• Integration in small- or large-scale batch reactors for specialty chemical output.

Final product types

• N-alkylpyrrolidones for high-performance coatings
• Pyrrolidone-based adhesives for electronics
• Specialty polymer intermediates
• Functionalized resin additives

3. Agrochemical Intermediate for Plant Growth Regulator Synthesis

Agrochemical manufacturers leverage Alpha-Amino-Gamma-Butyrolactone Hydrobromide as a source material in the preparation of amino acid-derived plant growth regulators. It enters the synthetic pathway during aminolactone ring opening or conversion to target carboxylic acids and amides. Reliable batch reproducibility ensures consistent downstream biological activity. Plant operators track input ratios and maintain strict reaction timing to meet agricultural ingredient registration. Quality control teams focus on trace bromide content and isomeric purity, ensuring safety for end applications in regulated markets.

Industry compliance standards

• FAO/WHO guidelines for pesticide and agrochemical purity
• ISO 17025 accredited analytical requirement
• European Commission Regulation (EC) No 1107/2009 for plant protection product approval
• China GB2763 residue standards (where applicable)

Typical usage ratio

• 12%–18% by mass relative to plant regulator substrate, with modifications based on the crop target and country-specific application guidelines.

Downstream process integration

• Input at the aminolactone ring-opening phase in plant regulator synthesis.
• Applied in controlled-reaction vessels for conversion to plant-protective acids or amides.
• Integrated immediately before final neutralization or salt-forming stages.

Final product types

• Plant growth regulators for vegetables and grains
• Chemical intermediates for selective herbicides
• Biostimulant formulation ingredients
• Agrochemical bulk mix components for export

4. Chiral Auxiliaries and Asymmetric Synthesis Applications

Manufacturers specializing in asymmetric synthesis processes use Alpha-Amino-Gamma-Butyrolactone Hydrobromide as a tailored chiral auxiliary. It enters asymmetric amination or carbonyl addition reactions, facilitating stereoselective transformation of prochiral substrates. Technical teams adjust addition rates and solvent systems to maximize enantiomeric excess and optimize downstream yield for integration with target specialty chemicals. Cleanroom environments handle materials at defined purity ranges, while QC departments evaluate chiral purity with HPLC and NMR analytics as required by filing documentation.

Industry compliance standards

• Good Laboratory Practice (GLP, OECD principles)
• ISO 17034 Reference Material Producer accreditation
• 21 CFR Part 211 Subpart F for analytical laboratory controls
• REACH registration for specialty intermediates

Typical usage ratio

• 5%–15% molar equivalents; adjusted to support target substrate scale and desired optical activity, confirmed per batch.

Downstream process integration

• Insertion during the enantioselective reaction step in the manufacture of active chiral molecules.
• Employed at the initial chiral resolution or asymmetric induction stage.
• Utility in bench-scale and pilot-plant runs for new chemical entity validation.

Final product types

• Single-enantiomer intermediates for fine chemical synthesis
• Precursor chiral auxiliaries for API production
• Stereochemically pure specialty additives
• Custom chiral building blocks for academic and CRO research